These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30225613)

  • 1. How Heart Rate Should Be Controlled in Patients with Atherosclerosis and Heart Failure.
    da Silva RMFL; Borges ASR; Silva NP; Resende ES; Tse G; Liu T; Roever L; Biondi-Zoccai G
    Curr Atheroscler Rep; 2018 Sep; 20(11):54. PubMed ID: 30225613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
    Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
    Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate control in atrial fibrillation: choice of treatment and assessment of efficacy.
    Boriani G; Biffi M; Diemberger I; Martignani C; Branzi A
    Drugs; 2003; 63(14):1489-509. PubMed ID: 12834366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
    Kotecha D; Holmes J; Krum H; Altman DG; Manzano L; Cleland JG; Lip GY; Coats AJ; Andersson B; Kirchhof P; von Lueder TG; Wedel H; Rosano G; Shibata MC; Rigby A; Flather MD;
    Lancet; 2014 Dec; 384(9961):2235-43. PubMed ID: 25193873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the management of heart failure: the role of ivabradine.
    Müller-Werdan U; Stöckl G; Werdan K
    Vasc Health Risk Manag; 2016; 12():453-470. PubMed ID: 27895488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
    Canet E; Lerebours G; Vilaine JP
    Ann N Y Acad Sci; 2011 Mar; 1222():90-9. PubMed ID: 21434947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve).
    Böhm M; Perez AC; Jhund PS; Reil JC; Komajda M; Zile MR; McKelvie RS; Anand IS; Massie BM; Carson PE; McMurray JJ;
    Eur J Heart Fail; 2014 Jul; 16(7):778-87. PubMed ID: 24864045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivabradine in Management of Heart Failure: a Critical Appraisal.
    Orasanu G; Al-Kindi SG; Oliveira GH
    Curr Heart Fail Rep; 2016 Feb; 13(1):60-9. PubMed ID: 26797824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.
    Borer JS; Deedwania PC; Kim JB; Böhm M
    Am J Cardiol; 2016 Dec; 118(12):1948-1953. PubMed ID: 27780557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should β-blockers be used in patients with heart failure and atrial fibrillation?
    Mareev Y; Cleland JG
    Clin Ther; 2015 Oct; 37(10):2215-24. PubMed ID: 26391145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
    Swedberg K; Komajda M; Böhm M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
    Lancet; 2010 Sep; 376(9744):875-85. PubMed ID: 20801500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate as a prognostic marker and therapeutic target in acute and chronic heart failure.
    Oliva F; Sormani P; Contri R; Campana C; Carubelli V; Cirò A; Morandi F; Di Tano G; Mortara A; Senni M; Metra M; Ammirati E
    Int J Cardiol; 2018 Feb; 253():97-104. PubMed ID: 29249470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate and its reduction in chronic heart failure and beyond.
    Nikolovska Vukadinović A; Vukadinović D; Borer J; Cowie M; Komajda M; Lainscak M; Swedberg K; Böhm M
    Eur J Heart Fail; 2017 Oct; 19(10):1230-1241. PubMed ID: 28627045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heart rate and outcome in patients with acute and chronic heart failure].
    Oliva F; Ammirati E; Campana C; Carubelli V; Cirò A; Di Tano G; Mortara A; Senni M; Morandi F; Metra M
    G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 1):3S-16. PubMed ID: 27030005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate control in atrial fibrillation.
    Van Gelder IC; Rienstra M; Crijns HJ; Olshansky B
    Lancet; 2016 Aug; 388(10046):818-28. PubMed ID: 27560277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of heart rate and ivabradine in acute heart failure.
    Sciatti E; Vizzardi E; Bonadei I; Dallapellegrina L; Carubelli V
    Monaldi Arch Chest Dis; 2019 Oct; 89(3):. PubMed ID: 31594282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure.
    Pereira-Barretto AC
    Adv Ther; 2015 Oct; 32(10):906-19. PubMed ID: 26521191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate control in atrial fibrillation: looking beyond the average heart rate.
    Ahmad K; Dorian P
    Curr Opin Cardiol; 2006 Mar; 21(2):88-93. PubMed ID: 16470141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.